Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

169.75
BATS BZX Real-Time Price
As of 2:09pm ET
 +2.08 / +1.24%
Today’s Change
130.09
Today|||52-Week Range
181.81
+4.57%
Year-to-Date
3 Drugs Stocks Pushing Industry Growth
1:18pm / TheStreet.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Daniel Loeb's Third Point 2nd-Quarter 2016 Investor Letter
11:30am / GuruFocus News - Paid Partner Content
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
Amgen Still Has Many Ways to Win
8:11am / TheStreet.com - Paid Partner Content
Amgen (AMGN) Stock Rises on 'Non-Inferior' Late-Stage Trial Results
Jul 21 / TheStreet.com - Paid Partner Content
Amgen Inc: What to Watch in Q2 Earnings
Jul 26 / MotleyFool.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?
Jul 26 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?
Jul 21 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint
Jul 26 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
One Biotech Plays Red Light, Green Light With the FDA
Jul 26 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Jul 20 / MotleyFool.com - Paid Partner Content
Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise?
Jul 26 / Zacks.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?
Jul 26 / Zacks.com - Paid Partner Content
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG
Jul 18 / Zacks.com - Paid Partner Content
Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)
Jul 25 / Zacks.com - Paid Partner Content
Biotech dives into Sardinia gene pool for secret of long life
Jul 18 / FT.com - Paid Partner Content
3 Top Biotech Stocks to Buy Now
Jul 25 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks for Conservative Investors
Jul 17 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) Stock Down Ahead of Q2 Earnings Report
Jul 25 / TheStreet.com - Paid Partner Content
5 Figures to Look For When Johnson & Johnson Reports Its Second-Quarter Results
Jul 15 / MotleyFool.com - Paid Partner Content
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
Jul 25 / Zacks.com - Paid Partner Content
Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation
Jul 14 / Zacks.com - Paid Partner Content
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan
Jul 14 / Zacks.com - Paid Partner Content
I'm Bullish on Biotechs
Jul 25 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 14 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June
Jul 13 / MotleyFool.com - Paid Partner Content
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
Jul 25 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel ...
Jul 13 / Zacks.com - Paid Partner Content
Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?
Jul 25 / Zacks.com - Paid Partner Content
20 stocks to buy after Brexit chaos
Jun 28 / CNNMoney.com